Juan P. Negret
Well-known member
I would like to receive input in the following issue. I think this could be a useful information for someone facing valve selection.
For a specific model of a tissue valve, a population of patientes receive the valve in a certain year. Each year after that, there is a number (in percents) for the probability that a reoperation is needed for this population of patientes because the valve fails that year. This number rises year after year.
I would like to hear from you on your educated guess of the number of years that this population of patientes would have to wait until that probability rises above 50%.
To be more specific: the valve is the more durable of the Carpentier-Edwards Perimount Magna series for a mitral valve; the population of patients consist of quite typical 60 year-old males (who are not entirely sedentary but do not practice regular sports).
For a specific model of a tissue valve, a population of patientes receive the valve in a certain year. Each year after that, there is a number (in percents) for the probability that a reoperation is needed for this population of patientes because the valve fails that year. This number rises year after year.
I would like to hear from you on your educated guess of the number of years that this population of patientes would have to wait until that probability rises above 50%.
To be more specific: the valve is the more durable of the Carpentier-Edwards Perimount Magna series for a mitral valve; the population of patients consist of quite typical 60 year-old males (who are not entirely sedentary but do not practice regular sports).